Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | +6.01% | +6.19% | +62.16% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.59M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -19M | EV / Sales 2021 | - |
Net cash position 2021 | 23.78M | Net cash position 2022 | 6.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.66
x | P/E ratio 2022 |
-0.43
x | Employees | 18 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.97% |
Latest transcript on Bellerophon Therapeutics, Inc.
1 day | +6.01% | ||
1 week | +6.19% | ||
1 month | +8.89% | ||
3 months | +16.50% | ||
6 months | +76.99% | ||
Current year | +62.16% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.06 | +6.01% | 8,485 |
24-05-30 | 0.0566 | -1.75% | 150 |
24-05-29 | 0.0576 | -2.56% | 10,474 |
24-05-28 | 0.0591 | +4.64% | 940 |
24-05-24 | 0.0565 | +0.36% | 5,729 |
Delayed Quote OTC Markets, May 31, 2024 at 03:14 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+62.16% | 734K | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BLPH Stock